PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of Chemotherapy
Abstract
Authors
M. Cobo J. De Castro D. Isla I. Oyagüez V. Lozano A. Castro-Gomez